Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1982 Jul;48(1):1–18. doi: 10.1136/hrt.48.1.1

The frontiers of cardiomyopathy.

J F Goodwin
PMCID: PMC481195  PMID: 6123334

Full text

PDF
1

Images in this article

6Image
on p.6
8Image
on p.8
9Image
on p.9
11Image
on p.11

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amorim D. S., Dargie H. J., Heer K., Brown M., Jenner D., Olsen E. G., Richardson P., Goodwin J. F. Is there autonomic impairment in congestive (dilated) cardiomyopathy? Lancet. 1981 Mar 7;1(8219):525–527. doi: 10.1016/s0140-6736(81)92863-4. [DOI] [PubMed] [Google Scholar]
  2. BRIGDEN W., ROBINSON J. ALCOHOLIC HEART DISEASE. Br Med J. 1964 Nov 21;2(5420):1283–1289. doi: 10.1136/bmj.2.5420.1283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BRIGDEN W. Uncommon myocardial diseases; the non-coronary cardiomyopathies. Lancet. 1957 Dec 14;273(7007):1179–1184. doi: 10.1016/s0140-6736(57)90159-9. [DOI] [PubMed] [Google Scholar]
  4. BURCH G. E., WALSH J. J., BLACK W. C. Value of prolonged bed rest in management of cardiomegaly. JAMA. 1963 Jan 12;183:81–87. doi: 10.1001/jama.1963.03700020031008. [DOI] [PubMed] [Google Scholar]
  5. Bell J. A., Jenkins B. S., Webb-Peploe M. M. Clinical, haemodynamic, and angiographic findings in Löffler's eosinophilic endocarditis. Br Heart J. 1976 Jun;38(6):541–548. doi: 10.1136/hrt.38.6.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bell R., Barber P. V., Bray C. L., Beton D. C. Incidence of thyroid disease in cases of hypertrophic cardiomyopathy. Br Heart J. 1978 Nov;40(11):1306–1309. doi: 10.1136/hrt.40.11.1306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Braimbridge M. V., Darracott S., Chayen J., Bitensky L., Poulter L. W. Possibility of a new infective aetiological agent in congestive cardiomyopathy. Lancet. 1967 Jan 28;1(7483):171–176. doi: 10.1016/s0140-6736(67)91821-1. [DOI] [PubMed] [Google Scholar]
  8. COHEN J., EFFAT H., GOODWIN J. F., OAKLEY C. M., STEINER R. E. HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY. Br Heart J. 1964 Jan;26:16–32. doi: 10.1136/hrt.26.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cambridge G., MacArthur C. G., Waterson A. P., Goodwin J. F., Oakley C. M. Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J. 1979 Jun;41(6):692–696. doi: 10.1136/hrt.41.6.692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Criley J. M., Lewis K. B., White R. I., Jr, Ross R. S. Pressure gradients without obstruction. A new concept of "hypertrophic subaortic stenosis". Circulation. 1965 Dec;32(6):881–887. doi: 10.1161/01.cir.32.6.881. [DOI] [PubMed] [Google Scholar]
  11. Davidson N. M., Parry E. H. Peri-partum cardiac failure. Q J Med. 1978 Oct;47(188):431–461. [PubMed] [Google Scholar]
  12. Demakis J. G., Rahimtoola S. H., Sutton G. C., Meadows W. R., Szanto P. B., Tobin J. R., Gunnar R. M. Natural course of peripartum cardiomyopathy. Circulation. 1971 Dec;44(6):1053–1061. doi: 10.1161/01.cir.44.6.1053. [DOI] [PubMed] [Google Scholar]
  13. Doi Y. L., McKenna W. J., Gehrke J., Oakley C. M., Goodwin J. F. M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction. Am J Cardiol. 1980 Jan;45(1):6–14. doi: 10.1016/0002-9149(80)90213-1. [DOI] [PubMed] [Google Scholar]
  14. Dubost C., Maurice P., Gerbaux A., Bertrand E., Rulliere R., Vial F., Barrillon A., Prigent C., Carpentier A., Soyer R. The surgical treatment of constrictive fibrous endocarditis. Ann Surg. 1976 Sep;184(3):303–307. doi: 10.1097/00000658-197609000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Elliott C. M., Tajik A. J., Giuliani E. R., Gordon H. Idiopathic hypertrophic subaortic stenosis associated with cutaneous neurofibromatosis: report of a case. Am Heart J. 1976 Sep;92(3):368–372. doi: 10.1016/s0002-8703(76)80118-4. [DOI] [PubMed] [Google Scholar]
  16. Ferrans V. J., Morrow A. G., Roberts W. C. Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients. Circulation. 1972 Apr;45(4):769–792. doi: 10.1161/01.cir.45.4.769. [DOI] [PubMed] [Google Scholar]
  17. Fitchett D. H., Neto J. A., Oakley C. M., Goodwin J. F. Hydralazine in the management of left ventricular failure. Am J Cardiol. 1979 Aug;44(2):303–309. doi: 10.1016/0002-9149(79)90321-7. [DOI] [PubMed] [Google Scholar]
  18. Fowles R. E., Bieber C. P., Stinson E. B. Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. Circulation. 1979 Mar;59(3):483–491. doi: 10.1161/01.cir.59.3.483. [DOI] [PubMed] [Google Scholar]
  19. Frank M. J., Abdulla A. M., Canedo M. I., Saylors R. E. Long-term medical management of hypertrophic obstructive cardiomyopathy. Am J Cardiol. 1978 Dec;42(6):993–1001. doi: 10.1016/0002-9149(78)90687-2. [DOI] [PubMed] [Google Scholar]
  20. GOODWIN J. F. CARDIAC FUNCTION IN PRIMARY MYOCARDIAL DISORDERS. I. Br Med J. 1964 Jun 13;1(5397):1527–1533. doi: 10.1136/bmj.1.5397.1527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. GOODWIN J. F., GORDON H., HOLLMAN A., BISHOP M. B. Clinical aspects of cardiomyopathy. Br Med J. 1961 Jan 14;1(5219):69–79. doi: 10.1136/bmj.1.5219.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gilbert B. W., Pollick C., Adelman A. G., Wigle E. D. Hypertrophic cardiomyopathy: subclassification by m mode echocardiography. Am J Cardiol. 1980 Apr;45(4):861–872. doi: 10.1016/0002-9149(80)90133-2. [DOI] [PubMed] [Google Scholar]
  23. Goodwin J. F. An appreciation of hypertrophic cardiomyopathy. Am J Med. 1980 Jun;68(6):796–800. doi: 10.1016/0002-9343(80)90189-8. [DOI] [PubMed] [Google Scholar]
  24. Goodwin J. F. Congestive cardiomyopathy. Introduction, problems and aims of the Multicentre Research Project. Postgrad Med J. 1978 Jul;54(633):431–434. doi: 10.1136/pgmj.54.633.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Goodwin J. F. Hypertrophic cardiomyopathy: a disease in search of its own identity. Am J Cardiol. 1980 Jan;45(1):177–180. doi: 10.1016/0002-9149(80)90236-2. [DOI] [PubMed] [Google Scholar]
  26. Goodwin J. F., Krikler D. M. Arrhythmia as a cause of sudden death in hypertrophic cardiomyopathy. Lancet. 1976 Oct 30;2(7992):937–940. doi: 10.1016/s0140-6736(76)90896-5. [DOI] [PubMed] [Google Scholar]
  27. Goodwin J. F., Oakley C. M. The cardiomyopathies. Br Heart J. 1972 Jun;34(6):545–552. doi: 10.1136/hrt.34.6.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Goodwin J. F. Prospects and predictions for the cardiomyopathies. Circulation. 1974 Aug;50(2):210–219. doi: 10.1161/01.cir.50.2.210. [DOI] [PubMed] [Google Scholar]
  29. Gutgesell H. P., Speer M. E., Rosenberg H. S. Characterization of the cardiomyopathy in infants of diabetic mothers. Circulation. 1980 Feb;61(2):441–450. doi: 10.1161/01.cir.61.2.441. [DOI] [PubMed] [Google Scholar]
  30. Guz A., McHaffie D. The use of digitalis glycosides in sinus rhythm. Clin Sci Mol Med. 1978 Nov;55(5):417–421. doi: 10.1042/cs0550417. [DOI] [PubMed] [Google Scholar]
  31. Hanrath P., Mathey D. G., Siegert R., Bleifeld W. Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: an echocardiographic study. Am J Cardiol. 1980 Jan;45(1):15–23. doi: 10.1016/0002-9149(80)90214-3. [DOI] [PubMed] [Google Scholar]
  32. Hardarson T., De la Calzada C. S., Curiel R., Goodwin J. F. Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet. 1973 Dec 29;2(7844):1462–1467. doi: 10.1016/s0140-6736(73)92730-x. [DOI] [PubMed] [Google Scholar]
  33. Hewer R. The heart in Friedreich's ataxia. Br Heart J. 1969 Jan;31(1):5–14. doi: 10.1136/hrt.31.1.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ikram H., Fitzpatrick D. Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy. Lancet. 1981 Sep 5;2(8245):490–493. doi: 10.1016/s0140-6736(81)90881-3. [DOI] [PubMed] [Google Scholar]
  35. Ingham R. E., Mason J. W., Rossen R. M., Goodman D. J., Harrison D. C. Electrophysiologic findings in patients with idiopathic hypertrophic subaortic stenosis. Am J Cardiol. 1978 May 1;41(5):811–816. doi: 10.1016/0002-9149(78)90718-x. [DOI] [PubMed] [Google Scholar]
  36. Kawai C. Idiopathic cardiomyopathy. A study on the infectious-immune theory as a cause of the disease. Jpn Circ J. 1971 Jul;35(7):765–770. doi: 10.1253/jcj.35.765. [DOI] [PubMed] [Google Scholar]
  37. Krikler D. M., Davies M. J., Rowland E., Goodwin J. F., Evans R. C., Shaw D. B. Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J. 1980 Mar;43(3):245–251. doi: 10.1136/hrt.43.3.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Laks M. M., Morady F., Swan H. J. Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest. 1973 Jul;64(1):75–78. doi: 10.1378/chest.64.1.75. [DOI] [PubMed] [Google Scholar]
  39. Lepley D., Jr, Aris A., Korns M. E., Walker J. A., D'Cunha R. M. Endomyocardial fibrosis. A surgical approach. Ann Thorac Surg. 1974 Dec;18(6):626–633. doi: 10.1016/s0003-4975(10)64411-6. [DOI] [PubMed] [Google Scholar]
  40. Manasek F. J. Histogenesis of the embryonic myocardium. Am J Cardiol. 1970 Feb;25(2):149–168. doi: 10.1016/0002-9149(70)90576-x. [DOI] [PubMed] [Google Scholar]
  41. Maron B. J., Epstein S. E. Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet. Am J Cardiol. 1980 Jan;45(1):141–154. doi: 10.1016/0002-9149(80)90232-5. [DOI] [PubMed] [Google Scholar]
  42. Maron B. J., Epstein S. E., Roberts W. C. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol. 1979 Jun;43(6):1086–1102. doi: 10.1016/0002-9149(79)90139-5. [DOI] [PubMed] [Google Scholar]
  43. Maron B. J., Lipson L. C., Roberts W. C., Savage D. D., Epstein S. E. "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Am J Cardiol. 1978 Jun;41(7):1133–1140. doi: 10.1016/0002-9149(78)90870-6. [DOI] [PubMed] [Google Scholar]
  44. Maron B. J., Merrill W. H., Freier P. A., Kent K. M., Epstein S. E., Morrow A. G. Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation. 1978 Jun;57(6):1205–1213. doi: 10.1161/01.cir.57.6.1205. [DOI] [PubMed] [Google Scholar]
  45. Maron B. J., Roberts W. C., Edwards J. E., McAllister H. A., Jr, Foley D. D., Epstein S. E. Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation. Am J Cardiol. 1978 May 1;41(5):803–810. doi: 10.1016/0002-9149(78)90717-8. [DOI] [PubMed] [Google Scholar]
  46. Mason J. W., Billingham M. E., Ricci D. R. Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol. 1980 May;45(5):1037–1044. doi: 10.1016/0002-9149(80)90174-5. [DOI] [PubMed] [Google Scholar]
  47. McFarland K. F., Stefadouros M. A., Abdulla A. M., McFarland D. E. Hypercalcemia and idiopathic hypertrophic subaortic stenosis. Ann Intern Med. 1978 Jan;88(1):57–58. doi: 10.7326/0003-4819-88-1-57. [DOI] [PubMed] [Google Scholar]
  48. McHaffie D., Purcell H., Mitchell-Heggs P., Guz A. The clinical value of digoxin in patients with heart failure and sinus rhythm. Q J Med. 1978 Oct;47(188):401–419. [PubMed] [Google Scholar]
  49. McKenna W. J., Chetty S., Oakley C. M., Goodwin J. F. Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy. Am J Cardiol. 1980 Jan;45(1):1–5. doi: 10.1016/0002-9149(80)90212-x. [DOI] [PubMed] [Google Scholar]
  50. McKenna W. J., England D., Doi Y. L., Deanfield J. E., Oakley C., Goodwin J. F. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. Br Heart J. 1981 Aug;46(2):168–172. doi: 10.1136/hrt.46.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. McKenna W. J., Harris L., Perez G., Krikler D. M., Oakley C., Goodwin J. F. Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment. Br Heart J. 1981 Aug;46(2):173–178. doi: 10.1136/hrt.46.2.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. McKenna W., Harris L., Deanfield J. Syncope in hypertrophic cardiomyopathy. Br Heart J. 1982 Feb;47(2):177–179. doi: 10.1136/hrt.47.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Morrow A. G., Reitz B. A., Epstein S. E., Henry W. L., Conkle D. M., Itscoitz S. B., Redwood D. R. Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation. 1975 Jul;52(1):88–102. doi: 10.1161/01.cir.52.1.88. [DOI] [PubMed] [Google Scholar]
  54. Murgo J. P., Alter B. R., Dorethy J. F., Altobelli S. A., McGranahan G. M., Jr Dynamics of left ventricular ejection in obstructive and nonobstructive hypertrophic cardiomyopathy. J Clin Invest. 1980 Dec;66(6):1369–1382. doi: 10.1172/JCI109990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Olsen E. G., Symons C., Hawkey C. Effect of triac on the developing heart. Lancet. 1977 Jul 30;2(8031):221–223. doi: 10.1016/s0140-6736(77)92836-7. [DOI] [PubMed] [Google Scholar]
  56. Perloff J. K. Pathogenesis of hypertrophic cardiomyopathy: hypotheses and speculations. Am Heart J. 1981 Feb;101(2):219–226. doi: 10.1016/0002-8703(81)90669-4. [DOI] [PubMed] [Google Scholar]
  57. Polani P. E., Moynahan E. J. Progressive cardiomyopathic lentiginosis. Q J Med. 1972 Apr;41(162):205–225. [PubMed] [Google Scholar]
  58. Rosenberg A. M., Haworth J. C., Degroot G. W., Trevenen C. L., Rechler M. M. A case of leprechaunism with severe hyperinsulinemia. Am J Dis Child. 1980 Feb;134(2):170–175. doi: 10.1001/archpedi.1980.02130140044014. [DOI] [PubMed] [Google Scholar]
  59. Rosing D. R., Condit J. R., Maron B. J., Kent K. M., Leon M. B., Bonow R. O., Lipson L. C., Epstein S. E. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration. Am J Cardiol. 1981 Sep;48(3):545–553. doi: 10.1016/0002-9149(81)90086-2. [DOI] [PubMed] [Google Scholar]
  60. Rosing D. R., Kent K. M., Borer J. S., Seides S. F., Maron B. J., Epstein S. E. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects. Circulation. 1979 Dec;60(6):1201–1207. doi: 10.1161/01.cir.60.6.1201. [DOI] [PubMed] [Google Scholar]
  61. Rosing D. R., Kent K. M., Maron B. J., Epstein S. E. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. Circulation. 1979 Dec;60(6):1208–1213. doi: 10.1161/01.cir.60.6.1208. [DOI] [PubMed] [Google Scholar]
  62. Sanderson J. E., Gibson D. G., Brown D. J., Goodwin J. F. Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study. Br Heart J. 1977 Jun;39(6):661–670. doi: 10.1136/hrt.39.6.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Sanderson J. E., Traill T. A., Sutton M. G., Brown D. J., Gibson D. G., Goodwin J. F. Left ventricular relaxation and filling in hypertrophic cardiomyopathy. An echocardiographic study. Br Heart J. 1978 Jun;40(6):596–601. doi: 10.1136/hrt.40.6.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Savage D. D., Seides S. F., Maron B. J., Myers D. J., Epstein S. E. Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation. 1979 May;59(5):866–875. doi: 10.1161/01.cir.59.5.866. [DOI] [PubMed] [Google Scholar]
  65. Sharma B., Goodwin J. F. Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy. Effect on systolic and diastolic function of the left ventricle. Circulation. 1978 Sep;58(3 Pt 1):449–460. doi: 10.1161/01.cir.58.3.449. [DOI] [PubMed] [Google Scholar]
  66. Sheikhzadeh A. H., Tarbiat S., Nazarian I., Aryanpur I., Senning A. Constrictive endocarditis. Report of a case with successful surgery. Br Heart J. 1979 Aug;42(2):224–228. doi: 10.1136/hrt.42.2.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Somerville J., Bonham-Carter R. E. The heart in lentiginosis. Br Heart J. 1972 Jan;34(1):58–66. doi: 10.1136/hrt.34.1.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Spry C. J., Tai P. C. Studies on blood eosinophils. II. Patients with Löffler's cardiomyopathy. Clin Exp Immunol. 1976 Jun;24(3):423–434. [PMC free article] [PubMed] [Google Scholar]
  69. Susa J. B., McCormick K. L., Widness J. A., Singer D. B., Oh W., Adamsons K., Schwartz R. Chronic hyperinsulinemia in the fetal rhesus monkey: effects on fetal growth and composition. Diabetes. 1979 Dec;28(12):1058–1063. doi: 10.2337/diab.28.12.1058. [DOI] [PubMed] [Google Scholar]
  70. Swan D. A., Bell B., Oakley C. M., Goodwin J. Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Br Heart J. 1971 Sep;33(5):671–685. doi: 10.1136/hrt.33.5.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Swedberg K., Hjalmarson A., Waagstein F., Wallentin I. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J. 1980 Aug;44(2):117–133. doi: 10.1136/hrt.44.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Swedberg K., Hjalmarson A., Waagstein F., Wallentin I. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet. 1979 Jun 30;1(8131):1374–1376. doi: 10.1016/s0140-6736(79)92010-5. [DOI] [PubMed] [Google Scholar]
  73. Symons C., Richardson P. J., Feizi O. Hypertrophic cardiomyopathy and hyperthyroidism: a report of three cases. Thorax. 1974 Nov;29(6):713–719. doi: 10.1136/thx.29.6.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. THOREN C. CARDIOMYOPATHY IN FRIEDREICH'S ATAXIA. WITH STUDIES OF CARDIOVASCULAR AND RESPIRATORY FUNCTION. Acta Paediatr. 1964;53:SUPPL 153–153:1+. [PubMed] [Google Scholar]
  75. Torp A. Incidence of congestive cardiomyopathy. Postgrad Med J. 1978 Jul;54(633):435–439. doi: 10.1136/pgmj.54.633.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Trueman T., Thompson R. A., Cummins P., Littler W. A. Heart antibodies in cardiomyopathies. Br Heart J. 1981 Sep;46(3):296–301. doi: 10.1136/hrt.46.3.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Upton M. T., Gibson D. G., Brown D. J. Echocardiographic assessment of abnormal left ventricular relaxation in man. Br Heart J. 1976 Oct;38(10):1001–1009. doi: 10.1136/hrt.38.10.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Waagstein F., Hjalmarson A., Varnauskas E., Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975 Oct;37(10):1022–1036. doi: 10.1136/hrt.37.10.1022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Williams E. M., Tasgal J., Raine A. E. Morphometric changes in rabbit ventricular myocardium produced by long-term beta-adrenoceptor blockade. Lancet. 1977 Oct 22;2(8043):850–852. doi: 10.1016/s0140-6736(77)90784-x. [DOI] [PubMed] [Google Scholar]
  80. Witzke D. J., Kaye M. P. Myocardial ultrastructural changes induced by administration of nerve growth factor. Surg Forum. 1976;27(62):295–297. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES